Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_3
2
25%
Ph phase_4
3
38%
Ph not_applicable
1
13%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(3)
Terminated(3)
Other(1)

Detailed Status

Completed3
Terminated2
Withdrawn1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 32 (25.0%)
Phase 43 (37.5%)
N/A1 (12.5%)

Trials by Status

withdrawn113%
unknown113%
not_yet_recruiting113%
completed338%
terminated225%

Recent Activity

0 active trials
Showing 5 of 8
not_yet_recruitingphase_4

The Effect of Piracetam on Diabetic Peripheral Neuropathy Patients

NCT06479629
unknownphase_4

Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker

NCT05918341
terminatedphase_3

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567
withdrawnphase_1

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

NCT00000199
completedphase_1

Piracetam for Treatment of Cocaine Addiction - 3

NCT00000198
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06479629Phase 4

The Effect of Piracetam on Diabetic Peripheral Neuropathy Patients

Not Yet Recruiting
NCT05918341Phase 4

Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker

Unknown
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT00000199Phase 1

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

Withdrawn
NCT00000198Phase 1

Piracetam for Treatment of Cocaine Addiction - 3

Completed
NCT00567060Not Applicable

Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)

Completed
NCT01883011Phase 4

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Terminated
NCT00190008Phase 3

Piracetam for Treatment Tardive Dyskinesia

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8